Ally Bridge Group (NY) LLC
NEW YORK, NY · CIK 1822947 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2021 · limited liability company
- Assets managed$218.9m
- Staff7 · 4 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $340.7m gross assets
- Form ADV · 2026-03-31SEC adviser record
- Legal entityALLY BRIDGE GROUP (NY) LLC (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, Miami, FL
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 3 |
| Miami, FLUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 2 call positions ($35.5m notional), 0 put positions (— notional) – listed below, not included above.
This report includes the holdings of 1 other manager that shares the investment decisions:
- Yu Fan – files its own report too
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MINERVA NEUROSCIENCES INC NERV | $12.1m15.56% | Added +520.3k |
| PROMIS NEUROSCIENCES INC PMN | $8.2m10.52% | Added +206.1k |
| FIRST TRACKS BIOTHERAPEUTICS TRAX | $5.7m7.37% | New |
| AXSOME THERAPEUTICS INC AXSM | $4.0m5.20% | New |
| ASSEMBLY BIOSCIENCES INC ASMB | $3.8m4.96% | New |
| AADI BIOSCIENCE INC WHWK | $3.7m4.83% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $3.4m4.36% | Reduced -77.7k |
| CLIMB BIO INC CLYM | $3.2m4.19% | New |
| KURA ONCOLOGY INC KURA | $3.2m4.10% | New |
| CYTOMX THERAPEUTICS INC CTMX | $2.9m3.75% | Reduced -125.0k |
| AVALO THERAPEUTICS INC AVTX | $2.8m3.57% | New |
| PALISADE BIO INC PALI | $2.6m3.31% | New |
| SOLID BIOSCIENCES INC SLDB | $2.6m3.30% | Reduced -511.0k |
| AN2 THERAPEUTICS INC ANTX | $2.5m3.28% | Unchanged |
| UROGEN PHARMA LTD URGN | $2.5m3.28% | Reduced -132.9k |
| PERSPECTIVE THERAPEUTICS INC CATX | $2.5m3.27% | Reduced -182.6k |
| IDEAYA BIOSCIENCES INC IDYA | $2.5m3.24% | New |
| INVENTIVA SA IVA | $2.4m3.09% | Reduced -110.5k |
| ALUMIS INC ALMS | $2.2m2.77% | Reduced -90.5k |
| OVID THERAPEUTICS INC OVID | $1.7m2.17% | Reduced -2.2m |
| EUPRAXIA PHARMACEUTICALS INC EPRX | $1.7m2.15% | Reduced -408.2k |
| IBIO INC IBIO | $682.8k0.88% | New |
| TRAWS PHARMA INC TRAW | $663.0k0.85% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| PRAXIS PRECISION MEDICINES I PRAX | $10.6m32.8k shares |
| SOLENO THERAPEUTICS INC SLNO | $6.7m200.0k shares |
| COMPASS PATHWAYS PLC CMPS | $5.8m1.0m shares |
| TARSUS PHARMACEUTICALS INC TARS | $5.7m80.9k shares |
| ABIVAX SA ABVX | $3.8m33.7k shares |
| CAPRICOR THERAPEUTICS INC CAPR | $3.5m113.9k shares |
| INHIBIKASE THERAPEUTICS INC IKT | $2.2m1.3m shares |
| RELMADA THERAPEUTICS INC RLMD | $1.5m210.5k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| DEFINIUM THERAPEUTICS INC DFTX · Call | $18.8m400.0k shares | New |
| ABIVAX SA ABVX · Call | $16.7m125.0k shares | New |